Discussion
Loading...

#Tag

  • About
  • Code of conduct
  • Privacy
  • Users
  • Instances
  • About Bonfire
The Japan Times
@thejapantimes@mastodon.social  ·  activity timestamp 3 days ago

AstraZeneca and Daiichi Sankyo’s drug Datroway has significantly improved survival and delayed the progression of breast cancer in patients with a particularly hard to treat form of the disease, AstraZeneca has said. https://www.japantimes.co.jp/business/2025/10/07/companies/astrazeneca-breast-cancer/?utm_medium=Social&utm_source=mastodon #business #companies #astrazeneca #daiichisankyo #health #cancer #medicine #pharmaceuticals

The Japan Times

Breast cancer patients lived longer on drug Datroway, says maker

The drug is said to have significantly improved survival and delayed disease progression in patients with a particularly hard to treat form of the disease.
  • Copy link
  • Flag this post
  • Block
The Japan Times
@thejapantimes@mastodon.social  ·  activity timestamp 5 days ago

The planned interventions in the American economy reverse decades of hands-off approach to private enterprise. https://www.japantimes.co.jp/business/2025/10/05/trump-white-house-deals-midterms/?utm_medium=Social&utm_source=mastodon #business #us #donaldtrump #pharmaceuticals #medicine #ai #mining #energy

The Japan Times

Trump targets deals in pharma, AI, energy and mining before midterm elections

Washington is pursuing deals across up to 30 industries, involving dozens of companies deemed critical to national or economic security.
  • Copy link
  • Flag this post
  • Block
The Japan Times
@thejapantimes@mastodon.social  ·  activity timestamp 2 weeks ago

U.S. President Donald Trump’s new tariffs on pharmaceutical imports will not apply to countries with negotiated agreements with the U.S. that contain provisions on drugs, according to a White House official. https://www.japantimes.co.jp/business/2025/09/27/economy/pharmaceutical-tariffs-wont-apply-japan/?utm_medium=Social&utm_source=mastodon #business #economy #tariffs #donaldtrump #trade #pharmaceuticals #us #japaneseeconomy #usjapanrelations

  • Copy link
  • Flag this post
  • Block
The Japan Times
@thejapantimes@mastodon.social  ·  activity timestamp 3 weeks ago

A twice-a-year injection, recently approved for HIV prevention in the U.S. and the European Union, helps solve the problem of adherence, Gilead argues. https://www.japantimes.co.jp/business/2025/09/22/companies/gilead-twice-a-year/?utm_medium=Social&utm_source=mastodon #business #companies #hiv #medicine #gilead #pharmaceuticals #nationalhealthcare

The Japan Times

Twice-a-year injection could make HIV prevention easier, developer argues

Without the need to take a daily pill, adherence could improve, says an executive from Gilead Sciences, which developed such an injection.
  • Copy link
  • Flag this post
  • Block
The Japan Times
@thejapantimes@mastodon.social  ·  activity timestamp 3 weeks ago

Trump administration officials plan to link the active ingredient in Tylenol to autism Monday, The Washington Post reported, citing unnamed people familiar with the matter. https://www.japantimes.co.jp/news/2025/09/22/world/politics/trump-link-tylenol-autism/?utm_medium=Social&utm_source=mastodon #worldnews #politics #tylenol #autism #pharmaceuticals #us #donaldtrump #health #medicine

The Japan Times

Trump administration to link Tylenol to autism, report says

Officials plan to warn pregnant women against using the medication, one of the world’s most common, over-the-counter pain relievers, unless they have a fever.
  • Copy link
  • Flag this post
  • Block
ProPublica
@ProPublica@newsie.social  ·  activity timestamp 3 weeks ago

Senators Demand Names of Foreign Drugmakers Skirting FDA Import Bans
---

Citing a recent ProPublica investigation, Rick Scott, R-Fla., and Kirsten Gillibrand, D-N.Y., said they had “urgent concerns” about the agency’s oversight of foreign drugmakers and whether medications coming into the U.S. are safe.
https://www.propublica.org/article/senators-letter-fda-drug-import-bans?utm_source=mastodon&utm_medium=social&utm_campaign=mastodon-post

#News #Health #FDA #Drugs #Pharmaceuticals #Government

ProPublica

“Unacceptable”: Prominent U.S. Senators Demand FDA Provide Names of Troubled Foreign Drugmakers Skirting Import Bans

Citing a recent ProPublica investigation, Rick Scott, R-Fla., and Kirsten Gillibrand, D-N.Y., said they had “urgent concerns” about the agency’s oversight of foreign drugmakers and whether medications coming into the U.S. are safe.
  • Copy link
  • Flag this post
  • Block
The Japan Times
@thejapantimes@mastodon.social  ·  activity timestamp 3 weeks ago

In fast-aging Japan, struggles with dementia are a common story. But researchers hope that future breakthroughs will help them rewrite the ending. https://www.japantimes.co.jp/news/2025/09/17/japan/science-health/dementia-research/?utm_medium=Social&utm_source=mastodon #japan #sciencehealth #aging #elderly #mentalhealth #alzheimer039s #medicine #pharmaceuticals #dementia #lecanemab #donanemab

The Japan Times

Japan’s front-line researchers see bright path ahead for dementia treatment

Four scientists at the forefront of dementia research speak about what kind of future they envision for people with the condition.
  • Copy link
  • Flag this post
  • Block
The Japan Times
@thejapantimes@mastodon.social  ·  activity timestamp last month

Takeda Pharmaceutical’s experimental narcolepsy drug has significantly improved outcome for patients in late-stage clinical trials, and could become the first treatment to target the disorder's root cause. https://www.japantimes.co.jp/news/2025/09/09/japan/science-health/takeda-narcolepsy/?utm_medium=Social&utm_source=mastodon #japan #sciencehealth #takeda #health #pharmaceuticals #sleep

  • Copy link
  • Flag this post
  • Block
The Japan Times
@thejapantimes@mastodon.social  ·  activity timestamp last month

After grappling with high production costs as a result of soaring energy prices in the wake of Russia's invasion of Ukraine, Europe's chemical producers are faced with fresh turmoil from U.S. import tariffs. https://www.japantimes.co.jp/business/2025/09/04/markets/trump-tariffs-europe-chemicals/?utm_medium=Social&utm_source=mastodon #business #markets #pharmaceuticals #eu #germany #us #donaldtrump #trade #tariffs #chemicals

  • Copy link
  • Flag this post
  • Block
The Japan Times
@thejapantimes@mastodon.social  ·  activity timestamp last month

Chinese companies are racing to make generic versions of popular branded weight-loss drugs after regulators restricted sale of cheap copies, slowing demand for raw ingredients the firms supplied over the past two years. https://www.japantimes.co.jp/business/2025/09/03/companies/chinese-companies-generics-us-weight/?utm_medium=Social&utm_source=mastodon #business #companies #china #pharmaceuticals #wegovy #elililly#novonordisk #fda

  • Copy link
  • Flag this post
  • Block
The Japan Times
@thejapantimes@mastodon.social  ·  activity timestamp 2 months ago

Shares in Chugai Pharmaceutical, Japan's largest drugmaker, have tumbled the most since 1977 after late-stage trial data on an obesity drug it licensed to Eli Lilly & Co. showed disappointing results. https://www.japantimes.co.jp/business/2025/08/08/companies/chugai-shares-sink/?utm_medium=Social&utm_source=mastodon #business #companies #chugai #health #pharmaceuticals #obesity

  • Copy link
  • Flag this post
  • Block
The Japan Times
@thejapantimes@mastodon.social  ·  activity timestamp 2 months ago

A health ministry panel approved a plan to cut the price of Lecanemab, an Alzheimer's drug that Japanese drugmaker Eisai and U.S. industry peer Biogen codeveloped, by 15% in Japan starting Nov. 1. https://www.japantimes.co.jp/news/2025/08/07/japan/science-health/japan-alzheimer-drug-price-cut/?utm_medium=Social&utm_source=mastodon #japan #sciencehealth #alzheimer039s #medicine #pharmaceuticals#eisai #health

  • Copy link
  • Flag this post
  • Block
The Japan Times
@thejapantimes@mastodon.social  ·  activity timestamp 2 months ago

A Kyoto University research team has developed a pain-reliever that is comparable to morphine but does not have serious side effects. https://www.japantimes.co.jp/news/2025/08/05/japan/japan-new-painkiller-comparable-to-morphine/?utm_medium=Social&utm_source=mastodon #japan #health #medicine #pharmaceuticals #cancer #kyotouniversity

  • Copy link
  • Flag this post
  • Block
The Japan Times
@thejapantimes@mastodon.social  ·  activity timestamp 2 months ago

Japan's Kobayashi Pharmaceutical will accelerate efforts to reform its corporate culture marked by workers' reliance on top management, Chairman Yoshihito Ota has said. https://www.japantimes.co.jp/business/2025/08/04/companies/kobayashi-pharmaceutical-corporate-culture-reform/?utm_medium=Social&utm_source=mastodon #business #companies #kobayashipharmaceutical #osaka #pharmaceuticals #health #corporategovernance

  • Copy link
  • Flag this post
  • Block
ProPublica
@ProPublica@newsie.social  ·  activity timestamp 2 months ago

The FDA is cracking down on a generic drugmaker that was the subject of a ProPublica investigation last year, citing problems with safety tests that delayed the recall of a faulty medicine linked to deaths in the U.S.
https://www.propublica.org/article/fda-letter-glenmark-pharmaceuticals?utm_source=mastodon&utm_medium=social&utm_campaign=mastodon-post

#News #FDA#Medicine#Safety#Drugs#Pharmaceuticals

  • Copy link
  • Flag this post
  • Block
The Japan Times
@thejapantimes@mastodon.social  ·  activity timestamp 3 months ago

The biotechnology industry is experiencing a tectonic shift, driven by Chinese drugmakers who have come a long way from their copycat days to challenge Western dominance on innovation. https://www.japantimes.co.jp/business/2025/07/14/tech/china-biotech-world-drug-pipeline/?utm_medium=Social&utm_source=mastodon #business #tech #biotech #pharmaceuticals #china #medicine

  • Copy link
  • Flag this post
  • Block
The Japan Times
@thejapantimes@mastodon.social  ·  activity timestamp 3 months ago

U.S. President Donald Trump has vowed to push forward with his aggressive tariff regime, stressing he would not offer additional extensions on country-specific levies set to now hit in early August. https://www.japantimes.co.jp/business/2025/07/09/markets/trump-tariff-copper-drugs/?utm_medium=Social&utm_source=mastodon #business #markets #us #donaldtrump #trade #tariffs #republicans #copper #pharmaceuticals

  • Copy link
  • Flag this post
  • Block
The Japan Times
@thejapantimes@mastodon.social  ·  activity timestamp 3 months ago

Kobayashi Pharmaceutical remains only halfway through overhauling its corporate governance, as it struggles to restore public trust after health problems linked to some of its dietary supplements more than a year ago. https://www.japantimes.co.jp/business/2025/07/08/companies/kobayashi-reform-founding-family/?utm_medium=Social&utm_source=mastodon #business #companies #kobayashipharmaceutical #pharmaceuticals #corporategovernance #koji #health #norikazutoyoda

  • Copy link
  • Flag this post
  • Block
The Japan Times
@thejapantimes@mastodon.social  ·  activity timestamp 3 months ago

Drug wholesaler Medipal Holdings is seeking merger and acquisition opportunities to diversify its business and combat slower growth in the market in Japan. https://www.japantimes.co.jp/business/2025/07/01/companies/japan-medipal-drug-firm-ma/?utm_medium=Social&utm_source=mastodon #business #companies #medipalholdings #pharmaceuticals #acquisitions #mergers

  • Copy link
  • Flag this post
  • Block
Log in

bonfire.cafe

A space for Bonfire maintainers and contributors to communicate

bonfire.cafe: About · Code of conduct · Privacy · Users · Instances
Bonfire social · 1.0.0-rc.3.13 no JS en
Automatic federation enabled
  • Explore
  • About
  • Members
  • Code of Conduct
Home
Login